
Metabolicstrong evidence
Semaglutide
GLP-1 agonist for metabolic optimization
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes. It has become widely known for its dramatic effects on weight management and is FDA-approved under brand names Ozempic and Wegovy.
⚙️ Mechanism of Action
Semaglutide mimics the GLP-1 hormone, stimulating insulin secretion, suppressing glucagon, slowing gastric emptying, and acting on brain appetite centers to reduce hunger and caloric intake.
✅ Benefits
- •Significant weight loss (15–20% body weight)
- •Improved glycemic control
- •Cardiovascular risk reduction
- •Reduced systemic inflammation
- •Potential neuroprotective effects
⚠️ Risks & Considerations
- •Nausea, vomiting, diarrhea (common initial side effects)
- •Pancreatitis risk (rare)
- •Gallbladder issues
- •Muscle mass loss without resistance training
- •Thyroid C-cell tumor risk (animal studies)
Latest Videos
11:21Semaglutide GLP-1 Review: My Honest Experience After 9 Months
Healthonaut
3,631·9 months ago
0:28Semaglutide Peptide
Oubre Medical
616·2 years ago
0:58What is the difference between Ozempic and Compounded Semaglutide?
Achieve Health And Weightloss
28,788·2 years ago
0:43Semaglutide vs Tirzepatide
DPC Health
52,741·1 year ago
9:00I Tried All The Fat Loss Peptides And THIS Happened!
Ryan Humiston
1,082,321·8 months ago
Quick Facts
💉
Dosing Range
0.25–2.4 mg/week (titrated up)
⏱️
Half-Life
~7 days
🔄
Typical Cycle
Ongoing (chronic therapy)
⚡
Time to Effect
2–4 weeks for appetite effects
Administration Routes
Subcutaneous injectionOral (Rybelsus)
Used in Stacks
Related Peptides

5-Amino-1MQ
A small molecule inhibitor of NNMT that boosts NAD+ levels and promotes fat metabolism without affecting appetite.

AOD-9604
A modified fragment of human growth hormone (hGH 176-191) that stimulates lipolysis and fat oxidation without affecting blood sugar or growth.

MOTS-c
A mitochondrial-derived peptide that acts as an exercise-induced metabolic regulator, improving insulin sensitivity and physical performance.